Protagenic Therapeutics pressure-regulating peptides showed excellent safety in the single-dose portion of the Phase I trial
Protagenic Therapeutics 压力调节肽在 I 期试验的单剂量部分表现出卓越的安全性
Protagenic Therapeutics pressure-regulating peptides showed excellent safety in the single-dose portion of the Phase I trial
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.